Additionally, we profiled and classified a total of 12 primary and recurrent glioma samples generated from our own cohort and predicted the IDH and 1p-19q statuses of 9 tumor fragments derived from biopsies of 3 distinct patients (Tables S1 and S2). This evidence concerns the gene IDH2 and central nervous system cancer.